跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 279 条关于
“Torii”
全部
279
临床试验
263
药物
2
机构
1
资讯
13
去年
Shionogi Receives Regulatory Clearance for Torii Pharmaceutical Acquisition, Tender Offer Proceeds
前天
Shionogi and Torii Win Japanese Approval for VTAMA Cream 0.5% in Pediatric Atopic Dermatitis
去年
Torii Pharmaceutical Submits NDA in Japan for Verrica's Molluscum Contagiosum Treatment, TO-208
去年
Shionogi to Acquire Japan Tobacco's Pharma Units for $1.1 Billion
2个月前
Verrica Doses First U.S. and Japanese Patients in Phase 3 COVE-3 Trial of YCANTH for Common Warts
去年
Shionogi to Acquire Japan Tobacco's Pharmaceutical Subsidiaries for $1.1 Billion
去年
Verrica Pharmaceuticals Launches Global Phase 3 Trial for YCANTH in Common Warts, Targeting 22 Million US Patients
上个月
Japan Approves VTAMA Cream 0.5% for Atopic Dermatitis in Children Under 12
8个月前
Verrica Pharmaceuticals Initiates Phase 3 Trial for VP-102 in Common Warts Treatment
去年
ALK's House Dust Mite SLIT-Tablet Phase 3 Trial Results Published in The Lancet Regional Health – Europe
第 1 页,共 2 页
上一页
下一页